Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection

Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection

Abstract Pulmonary hypertension (PH) complicates the treatment of interstitial lung disease (ILD) patients resulting in poor functional status and worse outcomes. Early recognition of PH in ILD is important for initiating therapy and considering lung transplantation. However, no standard exists rega...

書誌詳細
主要な著者:	Raj Parikh, Ippokratis Konstantinidis, David M. O'Sullivan, Harrison W. Farber
フォーマット:	論文
言語:	English
出版事項:	Wiley 2022-10-01
シリーズ:	Pulmonary Circulation
主題:	idiopathic pulmonary fibrosis interstitial lung disease prostacyclin pulmonary hypertension treprostinil
オンライン･アクセス:	https://doi.org/10.1002/pul2.12141

類似資料

The PH‐ILD Detection tool: External validation and use in patients with ILD
著者:: Raj Parikh, 等
出版事項: (2023-07-01)

Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients
著者:: Julia McSweeney, 等
出版事項: (2023-04-01)

Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil
著者:: Aparna C. Swaminathan, 等
出版事項: (2024-11-01)

Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration
著者:: Jenna M. Faircloth, 等
出版事項: (2023-03-01)

Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration
著者:: Jenna M. Faircloth, 等
出版事項: (2023-08-01)

The Importance of Dose Escalation in the Treatment of Pulmonary Arterial Hypertension with Treprostinil
著者:: Piotr Kędzierski, 等
出版事項: (2025-01-01)

Inhaled therapies targeting prostacyclin pathway in pulmonary hypertension due to COPD: systematic review
著者:: Abdullah A. Alqarni, 等
出版事項: (2023-08-01)

Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing
著者:: Shelsey W. Johnson, 等
出版事項: (2022-07-01)

INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)
著者:: Nicholas S. Hill, 等
出版事項: (2022-07-01)

Evolution of pulmonary hypertension in interstitial lung disease: a journey through past, present, and future
著者:: Ahmad Arslan, 等
出版事項: (2024-01-01)

PAH-specific therapy for pulmonary hypertension and interstitial lung disease: A systemic review and meta-analysis
著者:: Ning Zhao, 等
出版事項: (2022-11-01)

Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia
著者:: Maria S. Nashatyreva, 等
出版事項: (2023-01-01)

Unexpected Acceleration in Treprostinil Delivery Administered by a Lenus Pro® Implantable Pump in Two Patients Treated for Pulmonary Arterial Hypertension
著者:: Garance Kopp, 等
出版事項: (2020-10-01)

Reasons for refusing parenteral therapy: a qualitative study of patients with pulmonary arterial hypertension
著者:: Kellie Morland, 等
出版事項: (2021-10-01)

Interstitial Lung Abnormality in Asian Population
著者:: Gong Yong Jin
出版事項: (2024-04-01)

The application of metabolomics toward idiopathic pulmonary fibrosis and potential metabolomic value of diverse samples in interstitial lung diseases
著者:: Mingtao Liu, 等
出版事項: (2023-09-01)

CLINICAL PROFILE OF INTERSTITIAL LUNG DISEASES CASES
著者:: Gagiya Ashok K, 等
出版事項: (2012-03-01)

Converging Pathways: A Review of Pulmonary Hypertension in Interstitial Lung Disease
著者:: Alexandra Lawrence, 等
出版事項: (2024-09-01)

Pulmonary Hypertension in Interstitial Lung Disease: Updates in Disease, Diagnosis, and Therapeutics
著者:: Zachary A. Haynes, 等
出版事項: (2023-10-01)

Prostacyclin receptor agonist selexipag in a patient with high-risk idiopathic pulmonary arterial hypertension: a case report
著者:: E. A. Rezukhina, 等
出版事項: (2021-09-01)

Interstitial lung diseases with progressive pulmonary fibrosis: pathogenetic features and approaches to therapy
著者:: N. A. Kuzubova, 等
出版事項: (2020-11-01)

Therapeutic Potential of Treprostinil Inhalation Powder for Patients with Pulmonary Arterial Hypertension: Evidence to Date
著者:: Cassady SJ, 等
出版事項: (2024-06-01)

Osteopontin as a Biomarker in Interstitial Lung Diseases
著者:: David Iturbe-Fernández, 等
出版事項: (2024-05-01)

Multidisciplinary discussion for diagnosis of interstitial lung disease in real life
著者:: Sabina Anna Guler, 等
出版事項: (2016-05-01)

Increased expiratory flows identify early interstitial lung disease
著者:: Sami Mohammed Alyami, 等
出版事項: (2023-01-01)

Role of Telomere Length in Survival of Patients with Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
著者:: Sofía Tesolato, 等
出版事項: (2023-12-01)

Digital quantification of p16-positive foci in fibrotic interstitial lung disease is associated with a phenotype of idiopathic pulmonary fibrosis with reduced survival
著者:: Jonathan Keow, 等
出版事項: (2022-06-01)

Evaluation of progressive pulmonary fibrosis in non-idiopathic pulmonary fibrosis-interstitial lung diseases: a cross-sectional study
著者:: Özlem Erçen Diken, 等
出版事項: (2024-08-01)

Estimation of plasmic concentration of the brain natriuretic peptide in interstitial pulmonary diseases with pulmonary hypertension: clinical role
著者:: N A Mukhin, 等
出版事項: (2009-03-01)

Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis
著者:: Lianghua Xiao, 等
出版事項: (2024-09-01)

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management
著者:: Justin M. Oldham, 等
出版事項: (2017-08-01)

Altered prostanoid production by fibroblasts cultured from the lungs of human subjects with idiopathic pulmonary fibrosis
著者:: Pierson Richard, 等
出版事項: (2002-02-01)

Abnormal platelet aggregation in pediatric pulmonary hypertension
著者:: Stephanie S. Handler, 等
出版事項: (2022-07-01)

Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis
著者:: Avignat S. Patel, 等
出版事項: (2023-02-01)

Bibliometric analysis of the pirfenidone and nintedanib in interstitial lung diseases
著者:: Jia Liu, 等
出版事項: (2024-04-01)

Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapy
著者:: Hardin EA, 等
出版事項: (2016-11-01)

A Case of Interstitial Lung Disease-Related Pulmonary Hypertension Successfully Treated with Inhaled Iloprost
著者:: Ji Hoon Jang, 等
出版事項: (2024-08-01)

An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J)
著者:: Kazuya Ichikado, 等
出版事項: (2023-06-01)

Noninvasive determinants of pulmonary hypertension in interstitial lung disease
著者:: Phillip Joseph, 等
出版事項: (2023-01-01)

Pulmonary Hypertension in the Course of Interstitial Lung Diseases—A Personalised Approach Is Needed to Identify a Dominant Cause and Provide an Effective Therapy
著者:: Aneta Kacprzak, 等
出版事項: (2023-07-01)